Blog

Archive for the ‘genetics’ category: Page 381

Mar 14, 2019

Add 15 healthy years to the lives of 1 million people — YoLife.io — Tassilo Weber — Ira Pastor — IdeaXme

Posted by in categories: aging, biotech/medical, business, computing, DNA, genetics, health, life extension, science, transhumanism

Mar 13, 2019

NIH and top scientists call for moratorium on gene-edited babies

Posted by in categories: biotech/medical, genetics

Researchers are alarmed by “rogue human experimentation” using CRISPR in China.

Read more

Mar 12, 2019

Gene-edited food quietly arrives in restaurant cooking oil

Posted by in categories: bioengineering, biotech/medical, food, genetics

NEW YORK (AP) — Somewhere in the Midwest, a restaurant is frying foods with oil made from gene-edited soybeans. That’s according to the company making the oil, which says it’s the first commercial use of a gene-edited food in the U.S.

Calyxt said it can’t reveal its first customer for competitive reasons, but CEO Jim Blome said the oil is “in use and being eaten.”

The Minnesota-based company is hoping the announcement will encourage the food industry’s interest in the oil, which it says has no trans fats and a longer shelf life than other soybean oils. Whether demand builds remains to be seen, but the oil’s transition into the food supply signals gene editing’s potential to alter foods without the controversy of conventional GMOs, or genetically modified organisms.

Read more

Mar 11, 2019

We are happy to announce Dr. Nir Barzilai, Albert Einstein College of Medicine, as a speaker for the 2019 Undoing Aging Conference

Posted by in categories: biotech/medical, genetics, life extension

Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging.

“Nir is our keynote speaker this year because, quite honestly, if I’d only given him half an hour there is no way he could do justice to his role in our movement. His scientific contributions have been world-leading for decades, but in recent years he has done so much more: he has taken a prominent role in two important rejuvenation startups, and he has also employed his exceptional political skills in forging invaluable new understandings between the biomedical gerontology and regulatory communities. Plus, he’s almost as entertaining a speaker as me!”, says Aubrey de Grey.

Read more

Mar 10, 2019

APOE Gene Therapy In Clinical Trials To Prevent Alzheimer’s

Posted by in categories: biotech/medical, genetics, neuroscience

The APOE gene, or the “forgetting gene,” has been proven to influence Alzheimer’s risk. So a team of scientists is exploring the effect of gene therapy on people with the riskiest version of the gene.

If it works, the pay-off could be huge.

Gene therapy involves transplanting specific genetic material into human cells in order to correct genetic problems, and is typically attempted on diseases with a singular cause. Alzheimer’s doesn’t seem to have one singular cause — but since the risk of developing it is so strongly associated with the APOE gene, it’s certainly worth a try.

Read more

Mar 6, 2019

Genetically engineered immune cells wipe out lupus in mice

Posted by in categories: biotech/medical, genetics

Chimeric antigen receptor–T cell therapy—already approved for some cancers—might help human patients with the autoimmune disorder.

Read more

Mar 6, 2019

What to do with the lignin?

Posted by in categories: bioengineering, biological, genetics, space, sustainability

Learning to deal with lignin is important for recycling and space settlements. Unused biomass on space settlements and long-term voyages is something that just can’t be tolerated. The same problem exists in dealing with plant waste on earth. A new process helps convert it into a precursor for polyester, which can be used for all kinds of other materials.


Plant cells are composed of three main substances: cellulose, hemicellulose, and lignin. According to Yining Zeng, Michael E. Himmel, and Shi-You Ding in Biotechnology for Biofuels, the composition amounts to “40 to 50% of cellulose, 15 to 25% hemicelluloses, 20 to 25% lignin, and 5 to 10% other components.[1]” For the most part, the only truly useful part is the cellulose and the hemicellulose. The lignin is usually just thrown away. The most common use is fuel for heating units. That’s right. They just burn it.

lignin_procesing_into_polyester_precursor

Continue reading “What to do with the lignin?” »

Mar 6, 2019

San Francisco 2036: The Story of the First “Cyberian” Trillionaire and Countdown to the Singularity

Posted by in categories: genetics, robotics/AI, singularity, virtual reality

Going forward into our exponential future…


“By our very nature, we humans are linear thinkers. We evolved to estimate a distance from the predator or to the prey, and advanced mathematics is only a recent evolutionary addition. This is why it’s so difficult even for a modern man to grasp the power of exponentials. 40 steps in linear progression is just 40 steps away; 40 steps in exponential progression is a cool trillion (with a T) – it will take you 3 times from Earth to the Sun and back to Earth.” –Alex M. Vikoulov, The Syntellect Hypothesis: Five Paradigms of the Mind’s Evolution.

Today is a special day for me. My AI assistant Ava scheduled few hours aside from my otherwise busy daily lineup to relive select childhood and adolescence memories recreated in virtual reality with a help of a newly developed AI technique ‘Re: Live’. Ava is my smart home assistant, too. I can rearrange furniture in any room, for example, just by thinking. Digital landscape wallpaper is changed by Ava by knowing my preferences and sensing my moods.

Continue reading “San Francisco 2036: The Story of the First ‘Cyberian’ Trillionaire and Countdown to the Singularity” »

Mar 5, 2019

Doctors Say They’ve Permanently Cured a Patient’s HIV

Posted by in categories: biotech/medical, genetics

The reported cure could lead to a gene-editing treatment for H.I.V.

Read more

Mar 5, 2019

Advances in stem cell treatment give hope to millions with ‘incurable’ diseases

Posted by in categories: biotech/medical, genetics

The announcement that a London man has become the second in the world to be “functionally cured” of HIV is a major advance in stem cell transplant therapy.

The man — who wishes to remain anonymous — was given stem cells from a donor with genetic resistance to the disease and he has now been in long term remission for 18 months without medication.

The breakthrough comes ten years after the first such case of a patient with HIV going into sustained remission, known as the ‘Berlin Patient.’

Continue reading “Advances in stem cell treatment give hope to millions with ‘incurable’ diseases” »